- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Sage Therapeutics, Immunomedics and Myriad Genetics were among the premarket biotech stock movers on Monday.
Cramer points to Gilead's pipeline for its problems.
Those who thought we were ready to break down look foolish again.
Tesaro expects to file a new drug application before the end of the year for niraparib as a maintenance therapy for ovarian cancer.